Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Diclofenac Potassium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taro's Generic Diclofenac Potassium Receives Approval in US
    Taro's Generic Diclofenac Potassium Receives Approval in US

    14 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218011

    FDA
    14 Jun 2024
    Share Share
    Taro Pharma's Generic Diclofenac Potassium Receives Approval in the U.S
    Taro Pharma's Generic Diclofenac Potassium Receives Approval in the U.S

    14 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218011

    FDA
    14 Jun 2024
    Share Share
    Alkem Lab Generic Diclofenac Potassium Receives Approval in the U.S.
    Alkem Lab Generic Diclofenac Potassium Receives Approval in the U.S.

    20 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216635

    FDA
    20 Jul 2022
    Share Share
    Umedica Lab`s Generic Diclofenac PotassiumReceives Approval In US
    Umedica Lab`s Generic Diclofenac PotassiumReceives Approval In US

    11 May 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215750

    FDA
    11 May 2022
    Share Share
    Annora Pharma's Generic Diclofenac Potassium Receives Approval in the U.S.
    Annora Pharma's Generic Diclofenac Potassium Receives Approval in the U.S.

    04 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215375

    FDA
    04 Mar 2022
    Share Share
    Aurobindo Pharma`s Generic Vigabatrin Receives Approval In US
    Aurobindo Pharma`s Generic Vigabatrin Receives Approval In US

    23 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211856

    FDA
    23 Oct 2021
    Share Share